Paul G. Savas, Director at vTv Therapeutics Inc. (VTVT), bought 1,259 shares at $5.50 ($7K) on 2016-05-24, disclosed to the SEC on 2016-05-24.
Open-market purchase of $7k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.20 | 1,004 | $5K | 78.9% |
| 2 | $5.40 | 55 | $297 | 4.5% |
| 3 | $5.50 | 200 | $1K | 16.6% |
| Total | $5.26 avg | 1,259 | $7K | 100% |
| Filing → |
| SIGA | BUY | 2019-08-12 | $51K | — | Filing → |
| SIGA | BUY | 2018-11-19 | $28K | — | Filing → |
| SIGA | BUY | 2018-11-13 | $50K | — | Filing → |